Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J R Foster

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Basic & Clinical Pharmacology & Toxicology|July 6, 2021
Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodoneLouise Ladebo, Ahmad Y Abuhelwa, David J R Foster, et al.
European Journal of Clinical Pharmacology|September 18, 2007
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersMette L Jensen, David J R Foster, Richard N Upton, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
A phase I study of the GM-CSF antagonist E21RIan N Olver, Tim Hercus, Angel Lopez, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Basic & Clinical Pharmacology & Toxicology|July 6, 2021
Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodoneLouise Ladebo, Ahmad Y Abuhelwa, David J R Foster, et al.
European Journal of Clinical Pharmacology|September 18, 2007
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersMette L Jensen, David J R Foster, Richard N Upton, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
A phase I study of the GM-CSF antagonist E21RIan N Olver, Tim Hercus, Angel Lopez, et al.
Pageof 6